A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China
NCT02645396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8855
Last updated 2019-04-23
Summary
The purpose of this study is to assess the risk of congenital cytomegalovirus (cCMV) infection in newborns born to seropositive women.
Conditions
- Congenital Cytomegalovirus Infection
- Cytomegalovirus Infection Reactivation
Sponsors & Collaborators
- collaborator INDUSTRY
-
National Natural Science Foundation of China
collaborator OTHER_GOV -
Jun Zhang
lead OTHER
Principal Investigators
-
Jun Zhang, Professor · Xiamen University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2018-06-30
- Completion
- 2018-12-31
Countries
- China
Study Locations
More Related Trials
-
Cytomegalovirus (CMV) Infection in Amniotic Fluid
NCT00194142 ·Status: COMPLETED
-
Biomarkers of Cytomegalovirus Fetal Infection and Disease
NCT03090841 ·Status: UNKNOWN
-
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
NCT01251744 ·Status: COMPLETED ·Phase: NA
-
TT-CMV Observational Birth Cohort Study
NCT00907686 ·Status: COMPLETED
-
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
NCT01923636 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
NCT05754879 ·Status: COMPLETED
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
COVID-19 and Obstetric Transmission
NCT04418557 ·Status: COMPLETED
-
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
NCT01819519 ·Status: COMPLETED ·Phase: NA
-
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA
-
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT04615715 ·Status: COMPLETED ·Phase: NA
-
Observational Study of the Management of Infants With Congenital CMV
NCT05855889 ·Status: RECRUITING
-
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
NCT04568044 ·Status: ACTIVE_NOT_RECRUITING
-
Cytomegalovirus Shedding Characteristics in Pregnant Women
NCT04021628 ·Status: COMPLETED
-
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
NCT04388605 ·Status: ACTIVE_NOT_RECRUITING
-
Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota
NCT06479941 ·Status: RECRUITING
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Saliva PCR in Pregnant Women with COVID-19
NCT06735300 ·Status: COMPLETED
-
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy,
NCT04658810 ·Status: COMPLETED
-
Reducing Acquisition of CMV Through Antenatal Education
NCT03511274 ·Status: COMPLETED ·Phase: NA
-
Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy
NCT03973359 ·Status: UNKNOWN ·Phase: NA